Skip to main content
NanoRepro AG logo

NanoRepro AG — Investor Relations & Filings

Ticker · NN6 ISIN · DE0006577109 LEI · 3912008FCA63AGIMEV74 F Manufacturing
Open in API
Filings indexed 412 across all filing types
Latest filing 2023-08-07 Transaction in Own Shar…
Country DE Germany
Listing F NN6

About NanoRepro AG

https://www.nanorepro.com/en/

NanoRepro AG is a company specializing in the development, manufacturing, and distribution of CE-marked rapid diagnostic tests (self-tests) and food supplements. The products are designed for both home and professional use. The company's portfolio covers various health areas, including family planning, preventive healthcare, disease detection, food intolerances, allergies, and infectious diseases. The primary goal is to provide accuracy in self-diagnostics for rapid disease detection and health monitoring.

Recent filings

Filing Released Lang Actions
NanoRepro AG: Veroffentlichung von Kapitalmarktinformationen
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement dated August 7, 2023, titled "NanoRepro AG: Veröffentlichung von Kapitalmarktinformationen" (Publication of Capital Market Information). The key content revolves around the "Erwerb eigener Aktien: 12. Zwischenmeldung" (Acquisition of own shares: 12th interim report) under an ongoing share buyback program, detailing the number of shares repurchased between July 31, 2023, and August 4, 2023. This directly relates to the company transacting in its own shares. The filing type 'POS' (Transaction in Own Shares) is the most specific match for a report detailing share repurchase activities. Although it is a regulatory disclosure (indicated by EQS-News and EU regulations cited), the specific subject matter overrides the general 'RNS' fallback.
2023-08-07 German
NanoRepro AG: Lisa Jungst, buy
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section titled 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details the name of an individual (Lisa Jüngst), her position ('Member of the managing body'), and records specific transactions (Acquisition) involving company shares, including price, volume, and date. This content directly matches the definition for Director's Dealing.
2023-08-04 English
NanoRepro AG: Dr. Olaf Stiller, buy
Director's Dealing Classification · 100% confidence The document explicitly contains the header "Directors’ Dealings" and details a transaction (Acquisition) by a person discharging managerial responsibilities (Dr. Olaf Stiller, Member of the administrative or supervisory body) in the company's shares. This directly matches the definition for Director's Dealing (DIRS). The document is a formal notification of insider trading activity.
2023-08-02 English
NanoRepro AG: Johanna Stiller, buy
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains detailed information regarding a transaction (Acquisition) by a person closely associated with a member of the administrative body (Johanna Stiller, associated with Dr. Olaf Stiller). This directly matches the definition for Director's Dealing reports. The corresponding code is DIRS.
2023-08-02 English
NanoRepro AG: Veroffentlichung von Kapitalmarktinformationen
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement dated July 31, 2023, titled "NanoRepro AG: Veröffentlichung von Kapitalmarktinformationen" (Publication of Capital Market Information). The key content revolves around the "Erwerb eigener Aktien: 11. Zwischenmeldung" (Acquisition of own shares: 11th interim report) detailing the number of shares repurchased between July 24 and July 28, 2023, referencing EU regulations (Regulation (EU) No 596/2014 and Delegated Regulation (EU) 2016/1052) concerning market abuse and share buybacks. This directly corresponds to the definition of a company buying back or selling its own shares, which is classified as 'Transaction in Own Shares' (POS). Although it is an announcement, the specific nature of the content (detailed buyback report) makes POS more precise than the general RPA or RNS.
2023-07-31 German
NanoRepro AG: Veroffentlichung von Kapitalmarktinformationen
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement dated July 24, 2023, titled "NanoRepro AG: Veröffentlichung von Kapitalmarktinformationen" (Publication of Capital Market Information). The key content revolves around the "Erwerb eigener Aktien: 10. Zwischenmeldung" (Acquisition of own shares: 10th interim report) under the share buyback program, detailing the number of shares repurchased between July 17 and July 21, 2023. This directly relates to the company buying back or selling its own shares. According to the definitions, this corresponds to 'Transaction in Own Shares' (Code: POS). Although it is a report of transactions, the format is a regulatory news release announcing the details, but the core subject matter is the share repurchase activity itself, making POS a more specific fit than the general RPA or RNS.
2023-07-24 German

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.